Your browser doesn't support javascript.
loading
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach.
Zhu, Mengxuan; Chen, Erbao; Yu, Shan; Xu, Chen; Yu, Yiyi; Cao, Xin; Li, Wei; Zhang, Pengfei; Wang, Yan; Lian, Baofeng; Zhang, Shuirong; Qu, Yueting; Huang, Lujia; Shi, Weiwei; Cui, Yuehong; Qian, Li; Liu, Tianshu.
Afiliación
  • Zhu M; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Chen E; Center of Evidence-based medicine, Fudan University, Shanghai, 20032, P. R. China.
  • Yu S; Hepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, P. R. China.
  • Xu C; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Yu Y; Center of Evidence-based medicine, Fudan University, Shanghai, 20032, P. R. China.
  • Cao X; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Li W; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Zhang P; Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Wang Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Lian B; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Zhang S; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
  • Qu Y; Origimed Co. Ltd, Shanghai, 20032, P. R. China.
  • Huang L; Origimed Co. Ltd, Shanghai, 20032, P. R. China.
  • Shi W; Origimed Co. Ltd, Shanghai, 20032, P. R. China.
  • Cui Y; Origimed Co. Ltd, Shanghai, 20032, P. R. China.
  • Qian L; Origimed Co. Ltd, Shanghai, 20032, P. R. China.
  • Liu T; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 20032, P. R. China.
Cancer Commun (Lond) ; 42(10): 1032-1035, 2022 10.
Article en En | MEDLINE | ID: mdl-35851588

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2022 Tipo del documento: Article